Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,416.00    26.00 (1.09%)
Bid:
2,414.00
Ask:
2,418.00
Spread: 4.00 (0.166%)
Market Cap: £7.76b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

18 Apr 2018 07:00

RNS Number : 2113L
Bunzl PLC
18 April 2018
 

 

18 April 2018

 

BUNZL Q1 TRADING STATEMENT, ACQUISITIONS IN THE US AND

THE NETHERLANDS AND DIRECTORATE CHANGE

 

Bunzl plc, the international distribution and outsourcing Group, today announces its trading statement for the period since 31 December 2017.

 

Overall trading has been consistent with expectations at the time of the annual results announcement at the end of February. Group revenue in the first quarter has increased 7% at actual exchange rates. At constant exchange rates, revenue has risen by 14% compared to the same period last year due to underlying growth of approximately 6% and an impact from acquisitions, net of the disposal of OPM, of approximately 8%. The underlying revenue growth, which is principally due to the additional grocery business won, albeit at lower margins, in North America towards the end of 2016, is expected to return to more normal levels during the remainder of the year as the additional business in North America has now been fully absorbed.

 

The Company also announces that in early March it completed two further acquisitions in the US and the Netherlands.

 

Monte Package Company, which is based in Michigan, is engaged in the distribution of a variety of packaging products to fresh food growers and packers, principally in the eastern US. Revenue in 2017 was US$58 million.

 

Bunzl has also purchased QS Nederland, a provider of hygiene solution services primarily for washrooms with a focus on customers operating in the government, healthcare and foodservice sectors in the Netherlands. Revenue in 2017 was €6 million.

 

Finally the Company today announces that Patrick Larmon, who has been an executive director of the Company and Chief Executive Officer of the Bunzl North America business area since 2004, will be retiring from the Board and the Company with effect from 31 December 2018. He will be succeeded in his role as Chief Executive Officer of Bunzl North America by James McCool. James, who is a qualified accountant and holds a MBA, joined Bunzl in 1998 since when he has held a number of senior management positions in North America, most recently as Chief Financial Officer from 2014 to date and Regional Vice President from 2007 until 2013. He will become Chief Executive Officer Designate of Bunzl North America from 1 May 2018.

 

Commenting on the acquisitions, Frank van Zanten, Chief Executive of Bunzl, said:

 

"The purchase of Monte has further enhanced our business in North America serving the agriculture sector while the acquisition of QS complements and extends our existing cleaning & hygiene supplies business in the Netherlands. We are pleased to welcome the employees of both businesses to the Group."

 

Commenting on the retirement of Patrick Larmon, Frank van Zanten said:

 

"I would like to thank Pat for his significant contribution to Bunzl over the last 28 years. In addition to overseeing the successful development of our largest business area, he has also been responsible for building a strong leadership team and developing a robust succession plan. The appointment of Jim, who himself has extensive knowledge and experience of our operations, provides continuity for the business as we look forward to the next stage of its development. Pat will leave the Group with our gratitude and best wishes for the future."

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive

Brian May, Finance Director

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: +44 (0)20 7353 4200

 

 

Note:

 

The details relating to Patrick Larmon required by Section 430(2B) of the Companies Act 2006 can be found on www.bunzl.com in the Investors section under corporate governance (remuneration).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBXGDSXSBBGIR
Date   Source Headline
3rd Jun 202610:45 amRNSDirector/PDMR Shareholding
1st Jun 202610:15 amRNSTotal Voting Rights
1st Jun 202610:00 amRNSAdmission to Trading
8th May 20264:13 pmRNSDirector/PDMR Shareholding
7th May 20262:43 pmRNSDirector/PDMR Shareholding
6th May 202610:05 amRNSDirector/PDMR Shareholding
1st May 202611:15 amRNSTotal Voting Rights
22nd Apr 20264:15 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
13th Apr 20264:00 pmRNSDirector/PDMR Shareholding
9th Apr 202612:01 pmRNSDirector/PDMR Shareholding
1st Apr 20264:00 pmRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
31st Mar 20264:50 pmRNSDirector/PDMR Shareholding
20th Mar 20262:28 pmRNSDirector/PDMR Shareholding
18th Mar 20265:26 pmRNSDirector/PDMR Shareholding
17th Mar 20264:20 pmRNSAnnual Financial Report
16th Mar 20263:00 pmRNSDirector/PDMR Shareholding
16th Mar 20263:00 pmRNSDirector/PDMR Shareholding
11th Mar 20264:00 pmRNSDirector/PDMR Shareholding
11th Mar 20264:00 pmRNSDirector/PDMR Shareholding
10th Mar 20263:30 pmRNSDirector Declaration
10th Mar 20263:30 pmRNSDirector Declaration
9th Mar 202610:20 amRNSDirector/PDMR Shareholding
5th Mar 20265:15 pmRNSDirector/PDMR Shareholding
4th Mar 20264:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:45 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
2nd Mar 202610:00 amRNSDividend Declaration
2nd Mar 20267:00 amRNSFinal Results
3rd Feb 20265:00 pmRNSDirector/PDMR Shareholding
2nd Feb 202612:45 pmRNSTotal Voting Rights
13th Jan 20265:00 pmRNSDirector/PDMR Shareholding
7th Jan 20265:15 pmRNSDirector/PDMR Shareholding
6th Jan 202611:15 amRNSDirector/PDMR Shareholding
2nd Jan 202610:45 amRNSTotal Voting Rights
17th Dec 20257:00 amRNSTrading Statement
3rd Dec 202512:00 pmRNSDirector/PDMR Shareholding
1st Dec 202511:00 amRNSTotal Voting Rights
27th Nov 20259:00 amRNSAdditional Listing
26th Nov 20253:34 pmRNSPublication of Admission Particulars.
21st Nov 20255:30 pmRNSHolding(s) in Company
17th Nov 20255:34 pmRNSHolding(s) in Company
13th Nov 20259:00 amRNSAdditional Listing
5th Nov 20259:45 amRNSDirector/PDMR Shareholding
3rd Nov 20254:00 pmRNSHolding(s) in Company
3rd Nov 20253:29 pmRNSTotal Voting Rights
3rd Nov 20259:30 amRNSBlock listing Interim Review
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.